MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

12.03 3.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.6

Max

11.92

Põhinäitajad
By Trading Economics
Sissetulek	89M 109M
Müük	65M 104M
P/E Sektori keskmine	5.658 88.032
Kasumimarginaal	104.112
Töötajad	64
EBITDA	37M 57M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+50.47% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. märts 2026

Turustatistika
By TradingEconomics
Turukapital	135M 1B
Eelmine avamishind	8.5
Eelmine sulgemishind	12.03

Uudiste sentiment

By Acuity

50%

141 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. dets 2025, 22:20 UTC

Suurimad hinnamuutused turgudel

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31. dets 2025, 17:31 UTC

Suurimad hinnamuutused turgudel

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31. dets 2025, 16:30 UTC

Suurimad hinnamuutused turgudel

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31. dets 2025, 15:19 UTC

Suurimad hinnamuutused turgudel

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31. dets 2025, 15:17 UTC

Suurimad hinnamuutused turgudel

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31. dets 2025, 14:37 UTC

Suurimad hinnamuutused turgudel

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1. jaan 2026, 23:35 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

1. jaan 2026, 21:29 UTC

Omandamised, ülevõtmised, äriostud

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1. jaan 2026, 21:29 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Sold Stake in JV to Tata Steel

1. jaan 2026, 21:28 UTC

Omandamised, ülevõtmised, äriostud

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1. jaan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. jaan 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

31. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31. dets 2025, 21:13 UTC

Omandamised, ülevõtmised, äriostud

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31. dets 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31. dets 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31. dets 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31. dets 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31. dets 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31. dets 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31. dets 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31. dets 2025, 17:16 UTC

Suurimad hinnamuutused turgudel

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31. dets 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31. dets 2025, 17:00 UTC

Omandamised, ülevõtmised, äriostud

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31. dets 2025, 15:57 UTC

Omandamised, ülevõtmised, äriostud

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31. dets 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31. dets 2025, 15:02 UTC

Suurimad hinnamuutused turgudel

Nike Shares Rise After CEO Hill Buys $1M of Shares

31. dets 2025, 14:40 UTC

Omandamised, ülevõtmised, äriostud

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31. dets 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31. dets 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

50.47% tõus

12 kuu keskmine prognoos

Keskmine 17.5 USD 50.47%

Kõrge 22 USD

Madal 14 USD

Põhineb 6 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

141 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.